RGS

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

active · Rounds: 4 · Score: 0.54 · 2026-04-25

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochond

Score: 0.317 · neurodegeneration · 2026-04-18

## Mechanistic Overview Combination Gene Therapy Targeting RGS6 and Parkin or PINK1 to Address Mitochondrial Dysfunction

Combination RGS6 restoration plus D2-pathway modulation

Score: 0.310 · neurodegeneration · 2026-04-25

Combine subthreshold RGS6 rescue with D2-pathway modulation to test whether benefit requires convergent normalization of

PDE10A Inhibition to Bypass RGS6 Deficiency via cAMP Pathway Normalization

Score: 0.224 · neurodegeneration · 2026-04-18

## Mechanistic Overview PDE10A Inhibition to Bypass RGS6 Deficiency via cAMP Pathway Normalization starts from the claim

RGS6 isoform switching or small-molecule RGS6 activation as disease-modifying th

Score: 0.220 · neurodegeneration · 2026-04-25

Pursue either isoform-specific RGS6 engineering or pharmacologic RGS6 activation to enhance protective signaling. The de